美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

硅谷銀行

0.0060

+0.0000

成交量：- -

成交額：- -

市值：35.56萬

市盈率：0.00

高：0.0060

開：0.0060

低：0.0060

收：0.0060

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

BUZZ-Akebia Therapeutics 深入探討股票發行計劃

BUZZ-Akebia Therapeutics 深入探討股票發行計劃

更正-禮來計劃今年在新興市場推出減肥藥

更正-更新版 1-禮來首席財務官表示，禮來計劃於 2025 年在新興市場推出減肥藥

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SIVBQ"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SIVBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SIVBQ\",,,,,undefined,":{"symbol":"SIVBQ","market":"US","secType":"STK","nameCN":"硅谷銀行","latestPrice":0.006,"timestamp":1742414400000,"preClose":0.006,"halted":0,"volume":0,"delay":15,"changeRate":0,"change":0,"floatShares":53990110,"shares":59274992,"eps":25.35,"lyrEps":25.581907,"pbRate":0,"amount":0,"amplitude":0,"dividePrice":0,"prevYearClose":0.006,"fiveDayClose":0.006,"twentyDayClose":0.006},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SIVBQ\",,,,,undefined,":{"symbol":"SIVBQ","floatShares":53990110,"roa":"0.76%","roe":"9.78%","lyrEps":25.581907,"shares":59274992,"dividePrice":0,"high":0.006,"amplitude":0,"preClose":0.006,"low":0.006,"week52Low":0.0011,"pbRate":"0.00","psRate":"0.00","week52High":0.15,"institutionHeld":0,"latestPrice":0.006,"eps":25.35,"divideRate":0,"volume":0,"delay":15,"ttmEps":25.35,"open":0.006,"prevYearClose":0.006,"prevWeekClose":0.006,"prevMonthClose":0.006,"prevQuarterClose":0.006,"fiveDayClose":0.006,"twentyDayClose":0.006,"sixtyDayClose":0.006},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SIVBQ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-08","symbol":"SIVBQ","reason":null,"defaultRemindTime":1731076200000,"announcedDate":null,"type":"delisting","dateTimestamp":1731042000000},{"market":"US","date":"2023-10-19","symbol":"SIVBQ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1697688000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SIVBQ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SIVBQ\",market:\"US\",delay:true,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SIVBQ\",params:#limit:6,delay:true,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SIVBQ\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520195533","title":"BUZZ-Akebia Therapeutics 深入探討股票發行計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2520195533","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520195533?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 04:27","pubTimestamp":1742416041,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL4S3Q21M1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AKBA","SIVBQ","BK4211","BK4585","PIPR","BK4207","BK4589","BK4127","BK4139"],"gpt_icon":0},{"id":"2520195580","title":"BUZZ-Akebia Therapeutics 深入探討股票發行計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2520195580","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520195580?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 04:25","pubTimestamp":1742415909,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL4S3Q21LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SIVBQ","BK4585","BK4589","BK4139","BK4207","BK4127","PIPR","BK4211","AKBA","BK4588"],"gpt_icon":0},{"id":"2518420875","title":"更正-禮來計劃今年在新興市場推出減肥藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2518420875","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518420875?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 01:15","pubTimestamp":1741626940,"startTime":"0","endTime":"0","summary":"更新版 2-更正-礼来计划今年在新兴市场推出减肥药第3、4和8段增加了首席财务官的话，第7、9和10段增加了背景介绍。路透3月10日 - 礼来LLY.N财务总监周一表示，随着产能的增加，礼来计划于2025年下半年在印度、巴西和墨西哥等主要新兴市场推出其糖尿病和减肥药大片。礼来公司的这种药物去年在中国  有限上市，但该公司预计今年会有更大规模的上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4T3PT1E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU2357305700.SGD","LU1267930730.SGD","SG9999014914.USD","LU1989771016.USD","IE00BK4W5M84.HKD","LU0058720904.USD","LU2237443465.HKD","LU0466842654.USD","LU1988902786.USD","SIVBQ","LU0109391861.USD","LU2211815571.USD","SG9999014898.SGD","LU0708995401.HKD","LU1280957306.USD","LU0823416689.USD","LU0882574139.USD","IE00BJJMRZ35.SGD","LU0203201768.USD","LLY","LU2237443978.SGD","LU2237443549.SGD","IE0004445239.USD","LU1035775433.USD","SGXZ51526630.SGD","LU0820561909.HKD","LU1720051017.SGD","BK4211","IE0009355771.USD","LU0198837287.USD","LU2602419157.SGD","LU1720051108.HKD","SGXZ81514606.USD","LU1093756168.USD","LU2023250504.SGD","LU1548497426.USD","BK4516","LU1868837300.USD","SG9999001176.USD","LU1868836914.USD","SG9999018865.SGD","LU1127390331.HKD","LU2361045086.USD","LU0471298694.HKD","LU2360106947.USD","LU1064131342.USD","LU1983299246.USD","LU0689472784.USD","LU0820561818.USD"],"gpt_icon":1},{"id":"2518220490","title":"更正-更新版 1-禮來首席財務官表示，禮來計劃於 2025 年在新興市場推出減肥藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220490","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220490?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 22:17","pubTimestamp":1741616229,"startTime":"0","endTime":"0","summary":"更正-更新版 1-礼来首席财务官表示，礼来计划于 2025 年在新兴市场推出减肥药更正后的标题和报道称该药物将于2025年而不是2026年上市。路透3月10日 - 礼来LLY.N首席财务官卢卡斯-蒙塔斯周一表示，礼来计划于2025年在中国、印度、巴西和墨西哥等国推出其糖尿病和减肥特效药 \"Mounjaro\"。该药于去年获得了中国监管机构的批准 。去年 2 月，礼来公司首席执行官大卫-里克斯告诉  路透，该公司预计最早将于明年在印度推出 Mounjaro。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4S3PT14K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1623119135.USD","SG9999015986.USD","IE0004445239.USD","LU2461242641.AUD","LU1057294990.SGD","SG9999018857.SGD","LU0097036916.USD","LU0820561909.HKD","LU0256863811.USD","IE0009355771.USD","LU0385154629.USD","BK4516","SG9999014880.SGD","LU0203201768.USD","SG9999001176.USD","LU0882574055.USD","LU0094547139.USD","LU2211815571.USD","BK4007","IE00BJT1NW94.SGD","LU0354030511.USD","SGXZ31699556.SGD","LU0943347566.SGD","SGXZ51526630.SGD","LU0079474960.USD","LLY","LU1127390331.HKD","SG9999014898.SGD","LU1804176565.USD","LU0106261372.USD","LU1983299246.USD","LU2264538146.SGD","SG9999014906.USD","SIVBQ","IE0002141913.USD","LU2491050071.SGD","LU1023059063.AUD","SGXZ99366536.SGD","LU1712237335.SGD","LU0466842654.USD","LU0096364046.USD","SG9999001176.SGD","LU1061106388.HKD","BK4599","LU1551013342.USD","BK4533","LU0672654240.SGD","SG9999015952.SGD","LU0882574139.USD","LU2602419157.SGD"],"gpt_icon":1}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":51}]}}